New research highlighted at a symposium during an annual meeting for family physicians shows how nicotine withdrawal creates functional changes in the brains of smokers trying to quit causing cognitive performance deficits (such as ability to concentrate) that may make it more difficult to quit, and could be a driver of smoking relapse.1 Further, brain imaging technology shows that when treatment with the Commit® 4 mg nicotine lozenge is introduced, these symptoms of nicotine withdrawal can be reversed.2 This information is helping physicians better understand addiction and how treatment can help.
"The new research provides powerful new evidence as to why physicians need to intervene and help their patients understand and manage symptoms to help them quit successfully," said Dr. C. Everett Koop, former U.S. Surgeon General and driving force behind the 1988 Surgeon General's report entitled: The Health Consequences of Smoking: Nicotine Addiction. "Physicians should use these new data as reasons to speak with their patients to help them better understand their addiction, including the serious impact of withdrawal and how proven treatments can help reverse nicotine withdrawal symptoms that impact the brain."
To view Multimedia News Release, go to http://www.prnewswire.com/mnr/gsk/34594/